ArticleJournal of asthma and allergy2018

Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.

Pamela L Zeitlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.